Your session is about to expire
← Back to Search
Naps for Infant Memory Development
N/A
Recruiting
Research Sponsored by University of Massachusetts, Amherst
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Infants must be 9 months at the time of enrollment
Infants must have normal birthweight (5.5 to 10 lbs) and gestational length (36-41 weeks)
Must not have
Infants with visual or motor disability
Infants born premature (<36 weeks gestational age)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hours
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to study how naps affect memory development in infants aged 9 to 15 months. Memory is tested by observing if the child imitates a toy after seeing an experimenter interact
Who is the study for?
This trial is for infants aged 9 to 15 months to explore how napping affects their memory. Infants must be healthy with no sleep disorders like narcolepsy. They'll wear a motion-detecting watch and have electrodes on their head during naps at the study visits, which happen every three months.
What is being tested?
The study tests if there's a change in how babies remember things before and after they nap. Researchers will see if the way infants imitate actions with toys changes over time, from ages 9 to 15 months, by observing them before and after morning or afternoon naps.
What are the potential side effects?
There are minimal side effects expected in this study as it involves routine activities like wearing a watch and taking naps. However, some discomfort may occur from wearing the electrodes during sleep.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child is 9 months old.
Select...
My baby was born with a normal weight and at full term.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My infant has a visual or motor disability.
Select...
My baby was born before 36 weeks of pregnancy.
Select...
My infant has traveled across time zones within the last 2 weeks.
Select...
My infant has a fever or symptoms of a respiratory illness.
Select...
My infant has a physical handicap that affects vision or hearing.
Select...
My infant has had a neurological injury like seizures, brain tumor, or stroke.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Memory accuracy
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Wake (non-nap)Experimental Treatment1 Intervention
Wake is promoted
Group II: NapExperimental Treatment1 Intervention
Naps are promoted
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nap
2022
N/A
~1210
Find a Location
Who is running the clinical trial?
University of Maryland, College ParkOTHER
159 Previous Clinical Trials
46,363 Total Patients Enrolled
University of Massachusetts, AmherstLead Sponsor
81 Previous Clinical Trials
468,050 Total Patients Enrolled